Germany's Merck KGaA is looking at making further acquisitions to boost its business, according to chief executive Belén Garijo. The CEO – who is due to step down next April after five years in the ...

AI company Anthropic and the Gates Foundation have said they will provide $200 million in funding for a programme to support the development of AI for "health, life sciences, education, and economic ...

Khalil Asmar, VP of cardiometabolic health at Lilly UK & Ireland (l), and former England spin bowler Ashley Giles (r). Like ...

Regenxbio is pitching at FDA approval next year for its Duchenne muscular dystrophy (DMD) gene therapy RGX-202, after ...

Big Tech platforms continue to roll out AI health assistants at scale, with Amazon’s new agent the latest to be integrated ...

Bladder cancer has been billed by AstraZeneca as a key growth area for its immunotherapy Imfinzi, an ambition that has now ...

The Supreme Court of the US has ruled that the abortion pill mifepristone can continue to be prescribed remotely and delivered by mail-order, overruling an appeals court decision earlier this month.

In its second pipeline-expanding deal in the space of 24 hours, GSK has licensed rights to a drug for chronic obstructive pulmonary disease (COPD) from US biotech Empirico for $85 million upfront. The ...

MSD is scrapping a £1 billion ($1.35 billion) expansion of its UK operations – including a facility already under construction in London – saying the country does not value innovative medicines. The ...

UK reimbursement authority NICE has recommended that the NHS in England can use AstraZeneca's Imfinzi as the first ...